Comment on "Ensuring the Efficacy and Safety of Approved Medications "
J Med Toxicol
.
2024 Jul 27;20(3):330-331.
doi: 10.1007/s13181-024-01005-0.
Epub 2024 May 2.
Authors
J Oppenheimer
1
,
Thomas B Casale
2
,
Sarina Tanimoto
3
Affiliations
1
UMDNJ Rutgers University School of Medicine, Newark, New Jersey, USA.
2
Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
3
ARS Pharmaceuticals, Inc., 11682 El Camino Real, Suite 120, 92130, San Diego, California, USA. sarinat@ars-pharma.com.
PMID:
38696066
PMCID:
PMC11288218
DOI:
10.1007/s13181-024-01005-0
No abstract available
Keywords:
Anaphylaxis; Auto-injector; Epinephrine; Intranasal.
Publication types
Letter
MeSH terms
Drug Approval*
Drug-Related Side Effects and Adverse Reactions
Humans
United States
United States Food and Drug Administration